Quantcast

Latest MedImmune Stories

111779900
2011-08-22 20:39:39

A new study says that swine flu infections could trigger a rare sleeping disorder. The new study claims that rates of narcolepsy peak five to seven months after the highest levels of H1N1 infections and colds. The new research goes against some concerns that Pandemrix caused sleeping disorders in children in Finland. Researchers from Stanford medicine school in California said their study suggests that restrictions on the vaccine could actually lead to higher rates of infection....

2011-08-12 16:00:00

QUEBEC CITY, QC, Aug. 12, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced its operational and financial results for the second quarter ended June 30, 2011. The Company's financial statements and management report are available at www.sedar.com and at www.medicago.com. "During the second quarter, we made...

2011-08-11 09:53:00

ROCKVILLE, Md., Aug. 11, 2011 /PRNewswire/ -- Genovation Cars, a Maryland designer and builder of environmentally friendly automobiles, announced that it has received a product development grant from The Maryland Industrial Partnerships Program (MIPS), a historically effective innovation development program in the State of Maryland. The $135,110 grant will fund validation of the computational fluid dynamics (CFD) models of Genovation's plug-in electric G2 automobile at the Glenn L. Martin...

2011-08-11 07:00:00

BEIJING, Aug. 11, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it has obtained the GMP certificate for its seasonal flu vaccine and hepatitis A vaccine from the Mexican regulatory authority, the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) of Mexico Ministry of Health. Sinovac is the first Chinese vaccine manufacturer to be granted GMP certificate by COFEPRIS. The GMP...

2011-08-04 06:48:00

CRANBURY, N.J., Aug. 4, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) confirmed today the commencement of a Phase 1 clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist, under development as a single-agent therapy for the treatment of obesity. AZD2820 is a clinical candidate selected by AstraZeneca from its collaborative research program with Palatin Technologies. Obesity is a global problem, with the World Health...

2011-08-04 03:00:00

DALLAS, August 4, 2011 /PRNewswire/ -- ReportsnReports announces it will carry reports on Needle-Free Drug Delivery Market & Hospital-Acquired Infections (HAI) Diagnostics Market in its store A.Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics [http://www.reportsnreports.com/reports/117995-needle-free-drug-delivery-the-market-for-alternatives-to-needle-.html ] The coming decade will see drug delivery...

2011-07-26 20:50:25

Follow-up dose recommended to defend children against pandemic virus outbreak Researchers from Australia determined that pediatric liver transplant patients who received a single-dose of the H1N1 vaccine were not adequately protected against the virus compared to healthy children. This study appearing in the August issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases, found that a second vaccination was needed to elicit an effective immune...

2011-07-18 11:00:00

GAITHERSBURG, Md., July 18, 2011 /PRNewswire/ -- MedImmune announced today that it has begun shipping FluMist® (Influenza Vaccine Live, Intranasal) to influenza vaccine distributors who service health care providers throughout the United States. MedImmune expects to provide approximately 15 -16 million doses of its trivalent (three-strain) nasal spray flu vaccine for the 2011-2012 influenza season through a variety of private health care practices, public health...

2011-07-18 05:00:00

GAITHERSBURG, Md., July 18, 2011 /PRNewswire/ -- MedImmune has received confirmation from the U.S. Food & Drug Administration (FDA) that the Agency has filed the Company's supplemental Biologics License Application (sBLA) for a quadrivalent (four-strain) version of FluMist® (Influenza Vaccine Live, Intranasal). The company submitted the sBLA early in the second quarter of this year. Currently licensed seasonal influenza vaccines are trivalent, containing three strains...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related